To determine whether inhibiting peptidylarginine deiminase 4 (PAD4) and degrading extracellular DNA network effectively restrict NETs in hydrocephalus, we performed Cl‐amidine (a PAD4 inhibitor) and DNaseI treatment. The gene discussed is PADI4; the disease is Hydrocephalus.